Palisade Bio Inc. (NASDAQ: PALI)
$2.0100
N/A ( +2.03% ) 2.4K
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Market Data
Open
$2.0100
Previous close
$2.0100
Volume
2.4K
Market cap
$5.96M
Day range
$1.9700 - $2.1750
52 week range
$1.3800 - $22.3500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 54 | May 13, 2024 |
| 8-k | 8K-related | 17 | May 10, 2024 |
| 4 | Insider transactions | 1 | May 08, 2024 |
| 4 | Insider transactions | 1 | May 08, 2024 |
| 8-k | 8K-related | 21 | May 03, 2024 |
| 8-k | 8K-related | 43 | Apr 10, 2024 |
| 8-k | 8K-related | 16 | Apr 05, 2024 |
| 8-k | 8K-related | 15 | Mar 27, 2024 |
| 10-k | Annual reports | 74 | Mar 26, 2024 |
| 4 | Insider transactions | 1 | Mar 12, 2024 |